HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alteration of Gut Microbiota and Inflammatory Cytokine/Chemokine Profiles in 5-Fluorouracil Induced Intestinal Mucositis.

Abstract
Disturbed homeostasis of gut microbiota has been suggested to be closely associated with 5-fluorouracil (5-Fu) induced mucositis. However, current knowledge of the overall profiles of 5-Fu-disturbed gut microbiota is limited, and so far there is no direct convincing evidence proving the causality between 5-Fu-disturbed microbiota and colonic mucositis. In mice, in agreement with previous reports, 5-Fu resulted in severe colonic mucositis indicated by weight loss, diarrhea, bloody stool, shortened colon, and infiltration of inflammatory cells. It significantly changed the profiles of inflammatory cytokines/chemokines in serum and colon. Adhesion molecules such as vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and VE-Cadherin were increased. While tight junction protein occludin was reduced, however, zonula occludens-1 (ZO-1) and junctional adhesion molecule-A (JAM-A) were increased in colonic tissues of 5-Fu treated mice. Meanwhile, inflammation related signaling pathways including NF-κB and mitogen activated protein kinase (MAPKs) in the colon were activated. Further study disclosed that 5-Fu diminished bacterial community richness and diversity, leading to the relative lower abundance of Firmicutes and decreased Firmicutes/Bacteroidetes (F/B) ratio in feces and cecum contents. 5-Fu also reduced the proportion of Proteobacteria, Tenericutes, Cyanobacteria, and Candidate division TM7, but increased that of Verrucomicrobia and Actinobacteria in feces and/or cecum contents. The fecal transplant from healthy mice prevented body weight loss and colon shortening of 5-Fu treated mice. In addition, the fecal transplant from 5-Fu treated mice reduced body weight and colon length of vancomycin-pretreated mice. Taken together, our study demonstrated that gut microbiota was actively involved in the pathological process of 5-Fu induced intestinal mucositis, suggesting potential attenuation of 5-Fu induced intestinal mucositis by manipulating gut microbiota homeostasis.
AuthorsHong-Li Li, Lan Lu, Xiao-Shuang Wang, Li-Yue Qin, Ping Wang, Shui-Ping Qiu, Hui Wu, Fei Huang, Bei-Bei Zhang, Hai-Lian Shi, Xiao-Jun Wu
JournalFrontiers in cellular and infection microbiology (Front Cell Infect Microbiol) Vol. 7 Pg. 455 ( 2017) ISSN: 2235-2988 [Electronic] Switzerland
PMID29124041 (Publication Type: Journal Article)
Chemical References
  • Antigens, CD
  • Cadherins
  • Cell Adhesion Molecules
  • Chemokines
  • Cytokines
  • F11r protein, mouse
  • NF-kappa B
  • RNA, Ribosomal, 16S
  • Receptors, Cell Surface
  • Vascular Cell Adhesion Molecule-1
  • Zonula Occludens-1 Protein
  • cadherin 5
  • Intercellular Adhesion Molecule-1
  • Mitogen-Activated Protein Kinases
  • Fluorouracil
Topics
  • Animals
  • Antigens, CD (metabolism)
  • Bacteria (classification, drug effects, genetics, metabolism)
  • Body Weight (drug effects)
  • Cadherins (metabolism)
  • Cell Adhesion Molecules (metabolism)
  • Chemokines (metabolism)
  • Colon (metabolism, pathology)
  • Cytokines (metabolism)
  • Fecal Microbiota Transplantation
  • Feces (microbiology)
  • Fluorouracil (adverse effects)
  • Gastrointestinal Microbiome (drug effects)
  • Immunohistochemistry
  • Inflammation (complications, pathology)
  • Intercellular Adhesion Molecule-1 (metabolism)
  • Intestinal Mucosa (metabolism, pathology)
  • Intestines (pathology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mitogen-Activated Protein Kinases (metabolism)
  • Mucositis (chemically induced, metabolism, microbiology, pathology)
  • NF-kappa B (metabolism)
  • RNA, Ribosomal, 16S (genetics)
  • Receptors, Cell Surface (metabolism)
  • Vascular Cell Adhesion Molecule-1 (metabolism)
  • Zonula Occludens-1 Protein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: